Taking on vertical gardening with Topsy Turvy
HAWTHORNE, N.Y. — A new tomato planter that has gardening enthusiasts looking up now is available at retailers nationwide.
The Topsy Turvy upside-down tomato planter takes on the vertical gardening trend by saving space and time.
How it works: Plant the seedlings, hang the Topsy Turvy planter and water. The process helps avoid such typical gardening frustrations as fungus, harmful pests and labor-intensive garden maintenance, the company said.
Topsy Turvy also offers planters for strawberries, hot peppers and more.
The Topsy Turvy tomato planter is available for $9.99.
Survey: Majority of New Yorkers would shop at Walmart
NEW YORK — Walmart’s efforts to open in New York City were helped last week when a new poll, released Friday, found that New Yorkers would shop at Walmart if one opened in the city.
According to the Quinnipiac University poll, 68% of New Yorkers said that if it were convenient for them, they would shop at Walmart. That is compared with 29% who said they would not.
Nearly identical numbers of people said the chain’s lower prices would eat into small business sales.
Of those polled, 57% said they think elected officials should allow Walmart to move into the city, while 36% do not.
The new Quinnipiac poll surveyed about 1,100 registered voters between March 8 and March 14 and has a margin of error of +/- 2.9 percentage points.
Credit Suisse projects strong Q2 for WAG
NEW YORK — Following the recent sale of Walgreens’ pharmacy benefit management business, Credit Suisse analysts said they are interested in the executive team’s updated thinking on their healthcare strategy and plans for the $550 million in proceeds.
In a pre-results note issued Monday, Credit Suisse analysts said they projected second-quarter earnings per share for Walgreens to be at least 82 cents, 2 cents above consensus, as well as overall strong sales. Additionally, they noted that continued gross margin expansion will help the drug store chain beat Wall Street estimates.
"We expect its recent earnings momentum to continue. … We project a 40 bps improvement in the FIFO GM (versus +81 bps increase reported in the first quarter), with the deceleration attributed to more difficult [year-over-year] comparisons," wrote Credit Suisse research analyst Edward Kelly. "Management’s tone on the front-end margin has been positive, reflecting strong holiday sell-through and the continued emphasis on smarter promotions/more profitable sales growth. Pharmacy margins have less potential for upside in our view given the current lull in the generic cycle."
What’s more, the analysts referred to Walgreens’ selling, general and administrative expenses as a "key unknown" in the second quarter, stating that they assumed "stable two-year stacked growth but recognize that a continuation of last quarter’s momentum would provide upside to [our] estimate. We continue to believe full year [selling, general and administrative expense] will come in at the low end of the company’s 6.5% to 7.5% guidance."
Walgreens will report its second-quarter results on March 22.